Stifel Maintains Cipher Pharmaceuticals Inc(CPHRF.US) With Buy Rating, Cuts Target Price to $12.2
Stifel Maintains Cipher Pharmaceuticals Inc(CPHRF.US) With Buy Rating, Raises Target Price to $13.74
Stifel Maintains Cipher Pharmaceuticals Inc(CPHRF.US) With Buy Rating, Cuts Target Price to $12.4
Stifel Maintains Cipher Pharmaceuticals Inc(CPHRF.US) With Buy Rating, Raises Target Price to $12.62
Stifel Maintains Cipher Pharmaceuticals Inc(CPHRF.US) With Buy Rating, Cuts Target Price to $11.77
Stifel Upgrades Cipher Pharmaceuticals Inc(CPHRF.US) to Buy Rating, Raises Target Price to $11.64
Stifel Upgrades Cipher Pharmaceuticals to Speculative Buy, Raises Price Target to $4.75
No Data
No Data